管理与pegvaliase相关的皮肤问题:使用修改的Delphi方法的最佳实践建议
Alvaro Hermida Ameijeiras1, Erika Vucko2, Cary O Harding3
1Universidad de Santiago de Compostela (USC), Santiago, Spain.
Molecular genetics and metabolism
|February 28, 2026
概括
用佩格瓦酶 (PALYNZIQ®) 治疗的基尿症 (PKU) 患者的皮肤问题管理的最佳实践包括全面的教育,正确的注射技术和积极的药物使用. 这些策略旨在改善患者的坚持和患者的结果.
科学领域:
- 药理学 药理学是指药理学的学科.
- 皮肤病学 皮肤病学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 佩格瓦里亚斯 (PALYNZIQ®) 提供了一种新方法来管理基尿症 (PKU),允许饮食自由.
- 注射性佩格瓦利酶可以引起皮肤不良事件 (AE),需要管理.
- 积极的策略是必要的,以获得最佳的患者结局与 pegvaliase 治疗.
研究的目的:
- 建立最佳实践建议,以管理与PKU患者的二酶治疗相关的皮肤问题.
- 为临床医生和患者提供一个结构化的框架.
主要方法:
- 一个由八名临床医生组成的专家小组使用了经过修改的Delphi过程.
- 根据临床见解和文献审查,开发了39个初步陈述.
- 通过两轮匿名投票,以10分级进行评分,达成共识 (≥75%的同意).
主要成果:
- 在三个主题中完成了18份共识声明:以患者为中心的护理,药物策略和监测.
- 关键建议包括患者教育注射技术,注射点旋转和前期药物使用.
- 强调定期监测注射部位反应和痕组织,并达成高级小组协议 (8.5-10).
结论:
- 基于证据的建议提供了一个框架,用于管理与pegvaliase相关的皮肤问题.
- 实施这些指导方针可以提高治疗坚持和减轻AE.
- 改善皮肤问题的管理可能会导致PKU患者的整体治疗结果更好.
相关概念视频
01:26Peripheral Artery Disease IV: Nursing Management
497
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
497
01:19Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
01:27Peripheral Artery Disease III: Interprofessional Care
443
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
443
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54